Alpha-Thrombin Induces Rapid and Sustained Akt Phosphorylation by Beta-arrestin1-dependent and -independent Mechanisms, and Only the Sustained Akt Phosphorylation is Essential for G1 Phase Progression
Overview
Affiliations
In Chinese hamster embryonic fibroblasts (IIC9 cells) alpha-thrombin activates the MAPK(ERK) and phosphatidylinositol 3-OH-kinase (PI 3-kinase)/Akt pathways, and both are essential for progression through the G(1) phase of the cell cycle. We investigated in IIC9 cells, the role of beta-arrestin1 in alpha-thrombin signaling to these pathways. alpha-Thrombin stimulates rapid and sustained PI 3-kinase and Akt activities. Expression of a dominant negative beta-arrestin1 (beta-arrestin1(V53D)) inhibits rapid but not sustained PI 3-kinase and Akt activities. Surprisingly, expression of beta-arrestin1(V53D) does not block activation of the MAPK(ERK) pathway. PI 3-kinase and Akt activities are also inhibited by expression of a beta-arrestin1 mutant, which impairs binding to c-Src (beta-arrestin1(P91G-P121E)), indicating the involvement of c-Src in the rapid stimulation of the PI 3-kinase/Akt pathway. Consistent with these results, PP1, a selective inhibitor of c-Src family kinases, prevents alpha-thrombin-stimulated Akt phosphorylation. Expression of beta- arrestin1(V53D) does not prevent G(1) progression, as its expression has no effect on [(3)H]thymidine incorporation into DNA. In agreement with the ineffectiveness of beta-arrestin1(V53D) to block G(1) progression, cyclin D1 protein amounts and CDK4-cyclin D1 activity is unaffected by expression of beta-arrestin1(V53D). Thus in IIC9 cells, alpha-thrombin activates rapid beta-arrestin1-dependent and sustained beta-arrestin1-independent Akt activity, suggesting that two mechanisms are involved. Furthermore, although blocking the beta-arrestin1-independent PI 3-kinase/Akt pathway prevents G(1) progression, inhibition of the beta-arrestin1-dependent pathway does not, indicating different roles for the rapid and sustained activities.
Protease-activated receptors in health and disease.
Peach C, Edgington-Mitchell L, Bunnett N, Schmidt B Physiol Rev. 2022; 103(1):717-785.
PMID: 35901239 PMC: 9662810. DOI: 10.1152/physrev.00044.2021.
Gurubaran I, Helotera H, Marry S, Koskela A, Hyttinen J, Paterno J Biology (Basel). 2021; 10(7).
PMID: 34356477 PMC: 8301195. DOI: 10.3390/biology10070622.
Yang L, Hou Z, Tao Y Biochim Biophys Acta Mol Basis Dis. 2020; 1867(1):165973.
PMID: 32949766 PMC: 7722056. DOI: 10.1016/j.bbadis.2020.165973.
Niu S, Li H, Chen W, Zhao J, Gao L, Bo T Int J Endocrinol. 2018; 2018:4371396.
PMID: 29853881 PMC: 5954953. DOI: 10.1155/2018/4371396.
Zhang C, Hou L, Yang J, Che Y, Sun F, Li H Cell Death Dis. 2018; 9(2):60.
PMID: 29352205 PMC: 5833449. DOI: 10.1038/s41419-017-0091-7.